We helped I-Mak connect their powerful data to powerful voices

We collaborated with I-MAK by helping connect patients willing to share their lived experiences with barriers to GLP-1 access. Their stories added a vital human perspective to I-MAK’s data-driven report, which exposes how pharmaceutical patent tactics delay lower-cost alternatives from reaching patients. By bringing patient voices into the conversation, we helped highlight the real-world consequences of patent thickets and why reform is urgently needed.